Navigation Links
CamelBak(R) CEO Statement on BPA and Plastic Re-Usable Water Bottles
Date:4/9/2008

PETALUMA, Calif., April 9 /PRNewswire/ --

CamelBak is pleased to announce that our complete line of re-usable water bottles will be 100% BPA-free by the end of April, 2008. First to market in January with a BPA-free bottle offering clarity, durability and vibrant color, CamelBak will have an entirely BPA-free product line in North America. The line includes four styles: the CamelBak Better Bottle(TM) with Bite Valve, the CamelBak Better Bottle(TM) with Classic Cap, the CamelBak Podium(TM) Bottle and the CamelBak Performance(TM) Bottle.

The science surrounding BPA (bisphenol-A) can be confusing and contradictory. While we believe in the safety of all our products, enough consumers requested a BPA-free alternative that we re-engineered our bottles with an innovative new material to provide consumers with worry-free hydration.

Each year, Americans dispose of over 50 billion plastic water bottles. Only a fraction of those are recycled. Using a re-usable water bottle is an easy way for anyone to make a positive environmental impact. Using a CamelBak Better Bottle means that they can do so without having to worry about BPA.

Sally McCoy, CEO

CamelBak Products, LLC

For More Information:

Carson Stanwood

Carmichael Lynch Spong

(307) 733-1514

carson.stanwood@clynch.com


'/>"/>
SOURCE CamelBak Products, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
2. Statement of SEIU Spokesperson Andrew McDonald Responding to Announcement of Lawsuit by SEIU UHW-W
3. Statement from Lorillard Tobacco on FDA-Tobacco Regulation Legislation
4. Statement by the White House Press Secretary
5. Statement in Response to SEIU United Healthcare Workers - Wests (UHW-W) Thursday Media Event
6. CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders Equity
7. NCPA Statement on Californias Delay of E-Pedigree Implementation
8. American Academy of Dermatology Issues Statement Urging the Public to be Sun Smart(SM)
9. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
10. Pelosi Statement on Social Security and Medicare Trustees Reports
11. Media Alert: Statement on the Report of the Trustees of Social Security and Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael ... headquartered in Hamilton County, is embarking on a charity drive with the aim ... new homes for orphaned or neglected senior dogs in the Cincinnati region, and ...
(Date:12/8/2016)... Fort Payne, AL (PRWEB) , ... December 08, ... ... enterprise offering insurance and financial consulting services to residential and commercial clients in ... raise awareness and support for Nobis Works. , Since 1977, Nobis Works has ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (“Presence”) for a purchase price of approximately $17.4 million (net of the ... revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  A new study by a ... use of opioid therapy to treat chronic pain is ... of more harmful consequences, including death. Palliative ... Zankhana Mehta , M.D., authored the study which ... opioid therapy. The study was published in the December ...
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch die CFDA sowie ... – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the Chinese Congress ... Union Hospital ...
Breaking Medicine Technology: